In line with previous studies (9–13, 23–26), GSEA and GSVA analyses obtained herein demonstrated that FBXO5 might influence the pathogenesis or immunity of cancer by participating in the processes of DNA damage checkpoint, cellular senescence, inflammatory response, PI3K/Akt/mTOR signaling pathway, and p53 signaling pathway. The gene discussed is TP53; the disease is cancer.